Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 549-557

  Cersini, Antonella ^a   Salvia, Anna Maria ^a   Bernardini, Maria Lina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN POLYMERIZATION; AMINO ACID SYNTHESIS; ARTICLE; AUXOTROPHIC MUTANT; BACTERIUM MUTANT; CELL DIVISION; EFFECTOR CELL; EPITHELIUM CELL; GENE MUTATION; GENE REARRANGEMENT; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SHIGELLA FLEXNERI; TISSUE GROWTH;

EID: 0031932645     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.549-557.1998     Document Type: Article

References (55)

1. Adam, T., M. Arpin, M. C. Prevost, P. Gounon, and P. J. Sansonetti. 1995. Cytoskeletal rearrangements during entry of Shigella flexneri into HeLa cells. J. Cell Biol. 129:367-381.
2. Adam, T., M. Giry, P. Boquet, and P. J. Sansonetti. 1996. Rho-dependent membrane folding causes Shigella entry into epithelial cells. EMBO J. 15: 3315-3321.
3. Adlersberg, M., and D. B. Sprinson. 1964. Synthesis of 3,7-dideoxy-o-threohepto-2,6-diulosonic acid: a study in 5-dehydroquinic acid formation. Biochemistry 3:1855-1860.
4. Ahmed, Z. U., R. S. Mahfuzur, and D. A. Sack. 1990. Protection of adult rabbits and monkeys against shigellosis by oral immunization with a thyminerequiring and temperature-sensitive mutant of Shigella flexneri Y. Vaccine 8:153-158.
5. Alloui, A., J. Mounier, M.-C. Prevost, P. J. Sansonetti, and C. Parsot. 1992. icsB: a Shigella flexneri virulence gene necessary for the lysis of protrusions during intercellular spread. Mol. Microbiol. 6:1605-1616.
6. Bacon, G. A., T. W. Burrows, and M. Yates. 1951. The effects of biochemical mutation on the virulence of Bacterium typhosiun: the loss of virulence of certain mutants. Br. J. Exp. Pathol. 32:85-96.
7. Bernardini, M. L., et al. Unpublished results.
8. Bernardini, M. L., J. Mounier, H. d'Hauteville, M. Coquis-Rondon, and P. J. Sansonetti. 1989. Identification of icsA, a plasmid locus of Shigella flexneri that governs intra and intercellular spread through interaction with F-actin. Proc. Natl. Acad. Sci. USA 86:3867-3871.
9. Bochner, B. R., H. C. Huang, G. L. Schieven, and B. N. Ames. 1980. Positive selection for loss of tetracycline resistance. J. Bacteriol. 143:926-933.
10. Cossart, P. 1995. Actin-based bacterial motility. Curr. Opin. Cell Biol. 7:94-101.
11. Dehio, C., M. C. Prevost, and P. J. Sansonetti. 1995. Invasion of epithelial cells by Shigella flexneri induces tyrosine phosphorylation of cortactin by a pp60-src mediated signalling pathway. EMBO J. 14:2471-2482.
12. Egile, C., H. d'Hauteville, C. Parsot, and P. J. Sansonetti. 1997. SopA, the outer membrane protcase responsible for polar localization of IcsA in Shigella flexneri. Mol. Microbiol. 23:1063-1073.
13. Goldberg, M., O. Barzu, C. Parsot, and P. J. Sansonetti. 1993. Actin-binding and unipolar localization of IcsA, a Shigella flexneri protein involved in intracellular movement. J. Bacteriol. 175:2189-2196.
14. Goldberg, M. B., and A. J. Theriot. 1995. Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility. Proc. Natl. Acad. Sci. USA 92:6572-6576.
15. Goldberg, M. B., J. A. Theriot, and P. J. Sansonetti. 1994. Regulation of surface presentation of IcsA, a Shigella protein essential to intracellular movement and spread, is growth phase dependent. Infect. Immun. 62:5664-5668.
16. Hale, T. L. 1991. Genetic bases of virulence in Shigella species. Microbiol. Rev. 55:206-224.
17. Hale, T. L., R. E. Morris, and P. F. Bonventre. 1979. Shigella infection of Henle intestinal epithelial cells: role of the host cell. Infect. Immun. 24:887-894.
18. Hartman, A. B., C. J. Powell, C. L. Schultz, E. V. Oaks, and K. H. Eckels. 1991. Small-animal model to measure efficacy and immunogenicity of Shigello vaccine strains. Infect. Immun. 59:4075-4083.
19. Hilton, J. C., B. A. Cooper, and D. S. Rosenblatt. 1979. Folate polyglutamatc synthesis and turnover in cultured human fibroblasts. J. Biol. Chem. 254: 8398-8403.
20. Karnell, A., A. Li, C. R. Zhao, K. Karlsson, N. B. Minh, and A. A. Lindberg. 1995. Safety and immunogenicity study of the auxotrophic Shigella flexneri2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers. Vaccine 13:88-99.
21. Labrec, E. H., H. Schneider, T. J. Magnani, and S. B. Formal. 1964. Epithelial cell penetration as an essential step in pathogenesis of bacillary dysentery. J. Bacteriol. 88:1503-1518.
22. Lindberg, A. A., A. Kärnell, B. A. D. Stocker, S. Katakura, H. Sweiha, and F. Reinholt. 1988. Development of an auxotrophic oral live Shigella flexneri vaccine. Vaccine 6:1946-1950.
23. Lindberg, A. A., A. Kärnell, T. Pal, H. Sweiha, K. Hultenby, and B. A. D. Stocker. 1990. Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine. Microb. Pathog. 8:433-440.
24. Linde, K., V. Dentchev, V. Bondarensko, S. Marinova, B. Randhagen, M. Bratoyeva, Y. Tsvetanov, and Y. Romanova. 1990. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication. Vaccine 8:25-29.
25. MacSiomoin, R. A., N. Nakata, T. Murai, M. Yoshikawa, H. Tsuji, and C. Sasakawa. 1996. Identification and characterization of ispa, a Shigella flexneri chromosomal gene essential for normal in vivo cell division and intercellular spreading. Mol. Microbiol. 19:599-609.
26. Makino, S., C. Sasakawa, K. Kamata, T. Kurata, and M. Yoshikawa. 1986. A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in Shigella flexneri 2a. Cell 46:551-555.
27. Marquis, H., H. G. Bouwer, D. J. Hinrichs, and D. A. Portnoy. 1993. Intracytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants. Infect. Immun. 61:3756-3760.
28. Mathan, M. M., and M. V. Mathan. 1986. Ultrastructural pathology of the rectal mucosa in Shigella dysentery. Am. J. Pathol. 123:25-38.
29. Maurelli, A. T., B. Baudry, H. d'Hauteville, T. L. Hale, and P. J. Sansonetti. 1985. Cloning of plasmid DNA sequences involved in invasion of HeLa cells by Shigella flexneri. Infect. Immun. 49:164-171.
30. Maurelli, A. T., B. Blackmon, and R. Curtiss III. 1984. Temperature-dependent expression of virulence genes in Shigella species. Infect. Immun. 43: 397-401.
31. Ménard, R., P. J. Sansonetti, and C. Parsol. 1993. Non polar mutagenesis of ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906.
32. Millar, G., and J. R. Coggins. 1986. The complete aminoacid sequence of 3-dehydroquinate synthase of Escherichia coli K-12. FEBS Lett. 200:7-11.
33. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
34. Mounier, J., T. Vasselon, R. Hellio, M. Lesourd, and P. J. Sansonetti. 1992. Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole. Infect. Immun. 60:237-248.
35. Mounier, J., F. K. Bahrani, and P. J. Sansonetti. 1997. Secretion of Shigella flexneri Ipa invasins on contact with epithelial cells and subsequent entry of the bacterium into cells are growth stage dependent. Infect. Immun. 65:774-782.
36. Noriega, F. R., J. Y. Wang, G. Losonsky, D. R. Maneval, D. M. Hone, and M. M. Levine. 1994. Construction and characterization of attenuated ΔaroA and ΔicsA Shigella flexneri strain CVD 1203, a prototype live oral vaccine. Infect. Immun. 62:5168-5172.
37. Noriega, F. R., G. Losonsky, C. Lauderbaugh, F. M. Liao, J. Y. Wang, and M. M. Levine. 1996. Engineered ΔguaB-A ΔvirG Shigella flexneri 2a strain CVD 1205: construction, safety, Immunogenicity, and potential efficacy as a mucosal vaccine. Infect. Immun. 64:3055-3061.
38. Oaks, E. V., M. E. Wingfield, and S. B. Formal. 1986. Plaque formation by virulent Shigella flexneri. Infect. Immun. 48:124-129.
39. Okada, N., C. Sasakawa, T. Tobe, M. Yamada, S. Nakai, K. A. Talukder, K. Komatsu, S. Kanegasaki, and M. Yoshikawa. 1991. Virulence-associated chromosomal loci of Shigella flexneri identified by random Tn5 insertion mutagenesis. Mol. Microbiol. 5:187-195.
40. Parsot, C., and P. J. Sansonetti. 1995. Invasion and pathogenesis of Shigella infections. Curr. Top. Microbiol. Immunol. 209:25-42.
41. Richaud, C., D. Mengin-Lecreulx, S. Pochet, E. J. Johnson, G. N. Cohen, and P. Marliere. 1993. Directed evolution of biosynthetic pathways. J. Biol. Chem. 268:26827-26835.
42. Rong, N., J. Selhub, B. R. Goldin, and I. H. Rosenberg. 1991. Bacterially synthesized folate in rat large intestine is incorporated into host tissue folyl polyglutamate. J. Nutr. 121:1955-1959.
43. Sadlin, C. R., K. A. Lampel, S. P. Keasler, M. B. Goldberg, A. L. Stolzer, and A. T. Maurelli. 1995. Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect. Immun. 63:229-237.
44. Sansonetti, P. J., A. Ryter, P. Clerc, A. T. Maurelli, and J. Mounier. 1986. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect. Immun. 51:461-469.
45. Sansonetti, P. J., D. J. Kopecko, and S. B. Formal. 1982. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect. Immun. 35:852-860.
46. Sansonetti, P. J., J. Arondel, A. Fontaine, H. d'Hauteville, and M. L. Bernardini. 1991. ompB (osmo-regulation) and icsA (ceil-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis. Vaccine 9:416-422.
47. Sansonetti, P. J., and J. Arondel. 1989. Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis. Vaccine 7:416-422.
48. Sereny, B. 1955. Experimental Shigella conjunctivitis. Acta Microbiol. Acad. Sci. Hung. 2:293-296.
49. Simon, R., U. Priefer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Bio/Technology 1:784-791.
50. Suzuki, T., S. Saga, and C. Sasakawa. 1996. Functional analysis of Shigella VirG domains essential for interaction with vinculin and actin-based motility. J. Biol. Chem. 271:21878-21885.
51. Tran, V. N., G., A. Ben-Ze'ev, and P. J. Sansonetti. 1997. Modulation of bacterial entry in epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J. 10:2703-2717.
52. Verna, N. K., and A. A. Lindberg. 1991. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes. Vaccine 9:6-9.
53. Wanner, A., and L. Barry. 1986. Novel regulatory mutants of the phosphate regulon in E. coli K-12. J. Mol. Biol. 191:39-58.
54. Yoshikawa, M., C. Sasakawa, N. Okada, M. Takasaka, M. Nakayama, Y. Yoshikawa, A. Kohno, H. Danbara, H. Nariuchi, H. Shimada, and M. Toriumi. 1995. Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine. Vaccine 13: 1436-1440.
55. Zimmerman, H. 1992. 5′-Nucleotididase: molecular structure and functional aspects. Biochem. J. 285:345-365.